Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the CO-FLOW study
L. Bek (Rotterdam, Netherlands), J. Berentschot (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), R. Van Den Berg-Emons (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands)
Source: International Congress 2022 – Diagnosis, prevention and management of infectious respiratory diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bek (Rotterdam, Netherlands), J. Berentschot (Rotterdam, Netherlands), M. Heijenbrok-Kal (Rotterdam, Netherlands), G. Ribbers (Rotterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), R. Van Den Berg-Emons (Rotterdam, Netherlands), M. Hellemons (Rotterdam, Netherlands). Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the CO-FLOW study. 2447
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|